Aerosol precursor containing effective components of oral drug for treating rhinitis and method for dispersing effective components into nanoscale droplets

Abstract

The invention relates to an aerosol precursor containing effective components of an oral drug for treating rhinitis. The aerosol precursor comprises glycerine, propylene glycol, 1,3 butanediol, flavor components and oral dug extract for treating rhinitis, wherein the mass ratio of the glycerine to the propylene glycol to the 1,3 butanediol to the flavor components to the oral dug extract for treating rhinitis is (40-45):(20-25):(0-10):(0-10):(1-10). The invention further relates to a method for dispersing the effective components of the oral drug for treating rhinitis into nanoscale droplets, and an aerosol containing nanoscale droplets. The aerosol precursor contains the effective components of the oral drug for treating rhinitis, is placed in an electronic cigarette utensil containing an electric heating device to be heated to produce nanoscale droplets, and the human body can better absorb the effective components.

Description

technical field [0001] The invention relates to an aerosol precursor, in particular to an aerosol precursor containing an orally administered medicinal ingredient for treating rhinitis and a method for dispersing it into nano-scale droplets. Background technique [0002] Rhinitis is an inflammatory disease of the nasal cavity, which is the inflammation of the nasal mucosa caused by viruses, bacteria, allergens, various physical and chemical factors, and certain systemic diseases. The main pathological changes of rhinitis are congestion, swelling, exudation, hyperplasia, atrophy or necrosis of nasal mucosa. At present, the traditional Chinese medicine compound preparation for the treatment of rhinitis includes oral medication for the treatment of rhinitis. Usually, the administration method of the oral medication for the treatment of rhinitis is oral administration. On the one hand, the drug effect of this administration method is slow; Irritation to the stomach; on the othe...

AI Technical Summary

Problems solved by technology

[0005] The representative patent for pressurized atomization of traditional Chinese medicine compound preparations is CN102949573A, in which an 80-100bar propellant such as trichlorofluoromethane, dichlorodifluoromethane or dichlorotetrafluoroethane is used to atomize the liquid medicine to To obtain micron-sized mist droplets, the above-mentioned injection pressure is too high, the airtightness of the propellant container tank is strict, the production cost is high, and the propellant itself is also expensive

In addition, with the increase of the amount of medicine used, the pressure inside the tank decreases continuously, and the drug atomization effect gradually becomes worse; moreover, such tanks can only be used once for consumers, increasing usage cost